{"disease":{"id":"wet-age-related-macular-degeneration-wamd","name":"wet age related macular degeneration wamd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06839339","title":"Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Beijing Anlong Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06707753","title":"Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":21,"lead_sponsor_name":"Beijing Anlong Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06718816","title":"Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD","phase":"","overall_status":"RECRUITING","enrollment_count":21,"lead_sponsor_name":"Beijing Anlong Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06888492","title":"To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":8,"lead_sponsor_name":"Guangzhou Jiayin Biotech Ltd","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}